#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11866	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2168	539.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1415	1415	C	675	C,A	660,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	11866	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2168	539.1	0	HET	.	.	.	C207T,G	.	207	207	C	438	438	C	664	C,T,G	507,134,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3688	601.7	0	.	n	.	0	T695C	SNP	695	695	T	1112	1112	C	683	C,T	671,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3688	601.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	2055	2055	G	692	G	674	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3688	601.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2388	2388	C	673	C,G	662,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3688	601.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2462	2462	A	647	A,T	637,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22318	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3688	601.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3014	3014	C	657	C	644	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	512	22	blaTEM	861	342	99.71	blaTEM.l6.c4.ctg.1	342	3.0	0	.	p	.	0	M180T	NONSYN	538	540	ATG	315	317	ACG	3;3;3	A;C;G	3;3;3	.	Betalactam resistance
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	512	22	blaTEM	861	260	100.0	blaTEM.l6.c4.ctg.2	374	1.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	527	1606	folP	852	852	99.77	folP.l15.c4.ctg.1	1435	110.3	0	.	p	.	0	S68P	NONSYN	202	204	TCG	498	500	CCG	149;148;146	C;C;G	141;144;138	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	527	1606	folP	852	852	99.77	folP.l15.c4.ctg.1	1435	110.3	0	.	p	.	0	A204V	NONSYN	610	612	GCA	906	908	GTA	163;164;166	G;T,C;A,T	160;160,1;159,1	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	527	1606	folP	852	852	99.77	folP.l15.c4.ctg.1	1435	110.3	1	SNP	p	R228S	1	.	.	682	684	AGC	978	980	AGC	156;156;157	A;G;C,T	152;154;155,1	folP.WHO_G_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	527	1606	folP	852	130	99.23	folP.l15.c4.ctg.2	130	0.0	0	.	p	.	0	W92G	NONSYN	274	276	TGG	63	65	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4258	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3523	120.2	1	SNP	p	S91F	1	.	.	271	273	TTC	629	631	TTC	150;147;147	T;T;C	143;142;141	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4258	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3523	120.2	1	SNP	p	D95G	1	.	.	283	285	GGC	641	643	GGC	136;135;133	G;G,T;C	133;131,1;129	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4258	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3523	120.2	1	SNP	p	G95N	0	.	.	283	285	GGC	641	643	GGC	136;135;133	G;G,T;C	133;131,1;129	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1456	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1273	112.9	1	SNP	p	G45D	0	.	.	133	135	GGC	429	431	GGC	171;170;166	G;G;C	170;166;163	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	754	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	900	82.7	0	.	n	.	0	A197.	DEL	197	197	A	505	505	A	159	A	158	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4246	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2670	156.3	1	SNP	p	D86N	0	.	.	256	258	GAC	401	403	GAC	151;150;150	G;A;C	148;140;149	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4246	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2670	156.3	1	SNP	p	R87W	0	.	.	259	261	CGT	404	406	CGT	155;156;157	C;G;T	154;155;155	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4246	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2670	156.3	1	SNP	p	R87I	0	.	.	259	261	CGT	404	406	CGT	155;156;157	C;G;T	154;155;155	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4246	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2670	156.3	1	SNP	p	S87R	1	.	.	259	261	CGT	404	406	CGT	155;156;157	C;G;T	154;155;155	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4246	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2670	156.3	1	SNP	p	S88P	0	.	.	262	264	TCC	407	409	TCC	157;156;155	T;C;C	153;154;153	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3294	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2671	122.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1562	1564	GGC	167;164;160	G;G;C	166;162;156	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3152	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	128.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1305	1307	GCC	164;167;171	G;C;C	163;163;169	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3152	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	128.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1308	1310	ATG	170;167;168	A;T;G	167;164;163	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3152	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	128.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1320	1322	ACC	169;168;165	A;C;C	165;165;162	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3152	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	128.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1320	1322	ACC	169;168;165	A;C;C	165;165;162	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3152	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	128.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1821	1823	ACC	159;158;161	A;C;C	148;156;159	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3152	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	128.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1875	1877	GCG	146;147;147	G;C;G	145;144;145	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3152	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	128.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1875	1877	GCG	146;147;147	G;C;G	145;144;145	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3152	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	128.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1998	2000	GGT	109;107;105	G;G;T	107;105;101	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3152	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	128.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2007	2009	AGC	93;89;89	A;G;C,A	90;88;85,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3152	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2438	128.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2025	2027	CCG	85;87;88	C,G;C;G	73,1;76;70	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4764	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3028	155.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1593	1595	CCG	163;163;167	C;C,T;G,T,C	154;160,1;161,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2240	porA	1146	1146	99.91	porA.l15.c30.ctg.1	1923	115.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	589	589	C	154	C	145	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2280	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1764	128.6	1	SNP	p	G120K	1	.	.	358	360	AAG	700	702	AAG	158;157;160	A,T;A;G,A	149,1;152;145,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2280	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1764	128.6	1	SNP	p	A121N	1	.	.	361	363	AAC	703	705	AAC	163;165;166	A,G;A;C,A	155,1;159;154,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2280	porB1b	1038	1038	100.0	porB1b.l6.c17.ctg.1	1764	128.6	1	SNP	p	N121D	0	.	.	361	363	AAC	703	705	AAC	163;165;166	A,G;A;C,A	155,1;159;154,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8116	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4953	162.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	890	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1223	72.3	1	SNP	p	V57M	1	.	.	169	171	ATG	576	578	ATG	178;178;179	A;T;G	176;174;177	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
